Tim Preijers (T Preijers)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Venues

British journal of clinical pharmacology

Clinical pharmacokinetics

Journal of thrombosis and haemostasis : JTH

European journal of clinical pharmacology

Erasmus MC

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Erasmus MC

Netherlands

Resident Hospital Pharmacy :: Hopital Pharmacy

Academisch Medisch Centrum Geneeskunde Feb 01 2015 - Jan 31 2019

Netherlands

PhD Candidate :: Pharmacy

Publications

Sammy Huygens, Tim Preijers, Francis H Swaneveld, Ilona Kleine Budde, Corine H Geurts van Kessel, Birgit C P Koch, Bart J A Rijnders
Dosing of Convalescent Plasma and Hyperimmune Anti-SARS-CoV-2 Immunoglobulins: A Phase I/II Dose-Finding Study. Clinical pharmacokinetics 63 (4) (2024)
Tim Preijers, Anouk E Muller, Alan Abdulla, Brenda C M de Winter, Birgit C P Koch, Sebastiaan D T Sassen
Dose Individualisation of Antimicrobials from a Pharmacometric Standpoint: The Current Landscape. Drugs (2024)
Stef Schouwenburg, Fleur M Keij, Gerdien A Tramper-Standers, René F Kornelisse, Irwin K M Reiss, Pieter A J G de Cock, Evelyn Dhont, Kevin M Watt, Anouk E Muller, Robert B Flint, Birgit C P Koch, Karel Allegaert, Tim Preijers
A Pooled Population Pharmacokinetic Study of Oral and Intravenous Administration of Clavulanic Acid in Neonates and Infants: Targeting Effective Beta-Lactamase Inhibition. Clinical pharmacology and therapeutics (2024)
Sammy Huygens, Tim Preijers, Francis H Swaneveld, Ilona Kleine Budde, Corine H Geurts van Kessel, Birgit C P Koch, Bart J A Rijnders
Dosing of Convalescent Plasma and Hyperimmune Anti-SARS-CoV-2 Immunoglobulins: A Phase I/II Dose-Finding Study. Clinical pharmacokinetics 63 (4) (2024)
Sammy Huygens, Tim Preijers, Francis H Swaneveld, Ilona Kleine Budde, Corine H Geurts van Kessel, Birgit C P Koch, Bart J A Rijnders
Dosing of Convalescent Plasma and Hyperimmune Anti-SARS-CoV-2 Immunoglobulins: A Phase I/II Dose-Finding Study. Clinical pharmacokinetics 63 (4) (2024)
Sammy Huygens, Tim Preijers, Francis H Swaneveld, Ilona Kleine Budde, Corine H Geurts van Kessel, Birgit C P Koch, Bart J A Rijnders
Dosing of Convalescent Plasma and Hyperimmune Anti-SARS-CoV-2 Immunoglobulins: A Phase I/II Dose-Finding Study. Clinical pharmacokinetics (2024)
Lorenzo G R Romano, Nicole Geertruida Maria Hunfeld, Marieke J H A Kruip, Henrik Endeman, Tim Preijers
Population pharmacokinetics of nadroparin for thromboprophylaxis in COVID-19 intensive care unit patients. British journal of clinical pharmacology (2022)
Lorenzo G R Romano, Nicole Geertruida Maria Hunfeld, Marieke J H A Kruip, Henrik Endeman, Tim Preijers
Population pharmacokinetics of nadroparin for thromboprophylaxis in COVID-19 ICU patients. British journal of clinical pharmacology (2022)
Lorenzo G R Romano, Nicole Geertruida Maria Hunfeld, Marieke J H A Kruip, Henrik Endeman, Tim Preijers
Population pharmacokinetics of nadroparin for thromboprophylaxis in COVID-19 intensive care unit patients. British journal of clinical pharmacology (2022)
Tim Preijers, Lisette M Schütte, Marieke J H A Kruip, Marjon H Cnossen, Frank W G Leebeek, Reinier M van Hest, Ron A A Mathôt
Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia. Clinical pharmacokinetics 60 (1) (2021)
Tim Preijers, M W F van Spengler, K Meijer, K Fijnvandraat, K Fischer, F W G Leebeek, M H Cnossen, R A A Mathôt
In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients. European journal of clinical pharmacology (2021)
Tim Preijers, Ri Liesner, Hendrika C A M Hazendonk, Pratima Chowdary, Mariëtte H E Driessens, Dan P Hart, Britta A P Laros-van Gorkom, Felix J M van der Meer, Karina Meijer, Karin Fijnvandraat, Frank W G Leebeek, Ron A A Mathôt, Marjon H Cnossen, null null
Validation of a perioperative population factor VIII pharmacokinetic model with a large cohort of pediatric hemophilia a patients. British journal of clinical pharmacology 87 (11) (2021)
Iris van Moort, Tim Preijers, Hendrika C A M Hazendonk, Roger E G Schutgens, Britta A P Laros-van Gorkom, Laurens Nieuwenhuizen, Felix J M van der Meer, Karin C J Fijnvandraat, Frank W G Leebeek, Karina Meijer, Ron A A Mathôt, Marjon H Cnossen, null null
Dosing of factor VIII concentrate by ideal body weight is more accurate in overweight and obese haemophilia A patients. British journal of clinical pharmacology 87 (6) (2020)
Tim Preijers, Britta Ap Laros-vanGorkom, Ron Aa Mathôt, Marjon H Cnossen
Pharmacokinetic-guided dosing of factor VIII concentrate in a morbidly obese severe haemophilia A patient undergoing orthopaedic surgery. BMJ case reports 12 (1) (2019)
Tim Preijers, Hendrika C A M Hazendonk, R Liesner, P Chowdary, M H E Driessens, D Hart, D Keeling, B A P Laros-van Gorkom, F J M van der Meer, K Meijer, K Fijnvandraat, F W G Leebeek, P W Collins, M H Cnossen, R A A Mathôt, null null
Population pharmacokinetics of factor IX in hemophilia B patients undergoing surgery. Journal of thrombosis and haemostasis : JTH 16 (11) (2018)
Tim Preijers, Hendrika C A M Hazendonk, K Fijnvandraat, F W G Leebeek, M H Cnossen, R A A Mathôt
In silico evaluation of limited blood sampling strategies for individualized recombinant factor IX prophylaxis in hemophilia B patients. Journal of thrombosis and haemostasis : JTH 15 (9) (2017)

Tim Preijers.css-eqlu8i{font-size:small;padding-left:4px;} (T Preijers)

Publication Activity (10 Years)

Top Topics

Top Venues

Tim Preijers (T Preijers)